Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant

NCT05124509 · clinicaltrials.gov ↗

COMPLETED

Status

147

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection
Solid Organ Transplant
Vaccine Response Impaired

Interventions

BIOLOGICAL: Three doses of SARS-CoV-2 BNT162b2 vaccine (observational)
BIOLOGICAL: Two doses of CoronaVac and one dose of BNT162b2 SARS-CoV-2 vaccine (observational)

Sponsor

Pontificia Universidad Catolica de Chile